The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...

Argenx (NASDAQ:ARGX) is one of the best biotech stocks to invest in now. On June 20, Argenx announced that the European ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Approval of 45mg/0.5mL solution in a single-dose vial for subcutaneous injection expands dosing flexibility for pediatric patients with plaque psoriasis (PsO) or ...

Education before subcutaneous daratumumab administration can both reassure patients and reduce the occurrence of adverse ...

The injection takes just 3-5 min to administer, compared with 30-60 min for the intravenous (IV) infusion. Patients will still attend hospital every 2-4 weeks but will spend significantly less ...

"We are delighted that the subcutaneous injection of VYVGART® co-formulated with our ENHANZE drug delivery technology, has been recommended for approval in the European Union. The positive CHMP ...

Subcutaneous immunotherapy injections work the same way as their intravenous counterparts — by changing or enhancing a person’s immune responses to cancer. Immunotherapy for cancer is a broad ...

This article explores types of immunotherapy for upper GI cancer, how subcutaneous immunotherapy injections work, and considerations for when a doctor may add these types of therapies to a cancer ...

Notably, this interview came following the Dec. 27, 2024, Food and Drug Administration (FDA) approval of the subcutaneous injection formulation of Opdivo for patients with solid tumors. Intravenous ...

For patients, for example, who had to previously travel long distances for IV treatments, they now may be able to receive these subcutaneous under the skin injections locally. Because Opdivo is now ...